Gefitinib in Treating Patients With Cervical Cancer

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

October 31, 2002

Study Completion Date

August 31, 2006

Conditions

Cervical CancerFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer

Interventions

DRUG

gefitinib

OTHER

immunohistochemistry staining method

OTHER

surface-enhanced laser desorption/ionization-time of flight mass spectrometry

PROCEDURE

biopsy

PROCEDURE

sentinel lymph node biopsy

Trial Locations (2)

NCI - Center for Cancer Research, Bethesda

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00049556 - Gefitinib in Treating Patients With Cervical Cancer | Biotech Hunter | Biotech Hunter